3 scientists win Hong Kong’s Shaw Prize for developing therapy for rare leukaemia
Three scientists have been awarded Hong Kong's Shaw Prize in Life Science and Medicine for their groundbreaking work on treating acute promyelocytic leukaemia. Their research identified the molecular and cellular underpinnings of this rare blood cancer and led to the development of a targeted therapy using retinoic acid and arsenic. This innovative treatment has significantly reduced the mortality rate of the disease, transforming it from a deadly condition to one that is widely curable. AI
